An analytical framework for immunization programs in Canada
- PMID: 15752833
- DOI: 10.1016/j.vaccine.2004.10.029
An analytical framework for immunization programs in Canada
Abstract
Recent years have seen an increase in the number of new vaccines available on the Canadian market, and increasing divergence in provincial and territorial immunization programs as jurisdictions must choose among available health interventions with limited funding. We present an analytical framework, which we have developed to assist in the analysis and comparison of potential immunization programs. The framework includes 58 criteria classified into 13 categories, including the burden of disease, vaccine characteristics and immunization strategy, cost-effectiveness, acceptability, feasibility, and evaluability of program, research questions, equity, ethical, legal and political considerations. To date this framework has been utilized in a variety of different contexts, such as to structure expert presentations and reports and to examine the degree of consensus and divergence among experts, and to establish priorities. It can be transformed for a variety of other uses such as educating health professionals and the general public about immunization.
Similar articles
-
Decision support in vaccination policies.Vaccine. 2009 Oct 9;27(43):5923-8. doi: 10.1016/j.vaccine.2009.07.105. Epub 2009 Aug 19. Vaccine. 2009. PMID: 19698809 Review.
-
Optimizing the acceptability, effectiveness and costs of immunization programs: the Quebec experience.Expert Rev Vaccines. 2011 Jan;10(1):55-62. doi: 10.1586/erv.10.151. Expert Rev Vaccines. 2011. PMID: 21162621 Review.
-
Setting priorities for new vaccination programs by using public health officers and immunization managers opinions.Vaccine. 2008 Aug 5;26(33):4204-9. doi: 10.1016/j.vaccine.2008.05.061. Epub 2008 Jun 11. Vaccine. 2008. PMID: 18582998
-
Procedures and methods of benefit assessments for medicines in Germany.Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29. doi: 10.1007/s10198-008-0122-5. Eur J Health Econ. 2008. PMID: 18987905
-
[Procedures and methods of benefit assessments for medicines in Germany].Dtsch Med Wochenschr. 2008 Dec;133 Suppl 7:S225-46. doi: 10.1055/s-0028-1100954. Epub 2008 Nov 25. Dtsch Med Wochenschr. 2008. PMID: 19034813 German.
Cited by
-
From efficacy to equity: Literature review of decision criteria for resource allocation and healthcare decisionmaking.Cost Eff Resour Alloc. 2012 Jul 18;10(1):9. doi: 10.1186/1478-7547-10-9. Cost Eff Resour Alloc. 2012. PMID: 22808944 Free PMC article.
-
Perceptions of the seriousness of major public health problems during the COVID-19 pandemic in seven middle-income countries.Commun Med (Lond). 2023 Dec 21;3(1):193. doi: 10.1038/s43856-023-00377-8. Commun Med (Lond). 2023. PMID: 38129511 Free PMC article.
-
Parental intention to have daughters receive the human papillomavirus vaccine.CMAJ. 2007 Dec 4;177(12):1506-12. doi: 10.1503/cmaj.071022. CMAJ. 2007. PMID: 18056599 Free PMC article.
-
Parents' and healthcare professionals' perception toward the introduction of a new fully liquid hexavalent vaccine in the Malaysian national immunization program: a cross-sectional study instrument development and its application.Front Immunol. 2023 Apr 27;14:1052450. doi: 10.3389/fimmu.2023.1052450. eCollection 2023. Front Immunol. 2023. PMID: 37180162 Free PMC article.
-
Immunization in Canada: a 6-year update.J Can Chiropr Assoc. 2010 Jun;54(2):85-91. J Can Chiropr Assoc. 2010. PMID: 20520752 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources